29 Sep 2020 Celyad Oncology announces clinical trial collaboration to evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in patients with Microsatellite Stable mCRC Member news
27 Sep 2020 Jyseleca® (filgotinib) approved by European Commission for rheumatoid arthritis Member news
24 Sep 2020 Johnson & Johnson initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 vaccine candidate Member news
22 Sep 2020 Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study Member news
15 Sep 2020 Handl Therapeutics awarded a €3 million research grant by Flanders Innovation & Entrepreneurship (VLAIO) Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us